Amyotrophic Lateral Sclerosis Registry Rhineland-Palatinate

N/ACompletedNCT01955369

Klinikum Ludwigshafen200 enrolled

Overview

There is a lack of prospective and population-based epidemiological data on amyotrophic lateral sclerosis in Germany so far. The purpose of this registry is to investigate the incidence, course and phenotypic variety of ALS in Rhineland-Palatinate, a South-West German state of about 4 million inhabitants.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Amyotrophic Lateral Sclerosis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * diagnosis of amyotrophic lateral sclerosis according to revised El Escorial criteria * minimum of 18 years * minimum of 6 months of residency in Rhinelnad-Palatinate Exclusion Criteria: * patients below 18 years * ALS patients outside Rhineland-Palatinate

Locations (1)

Dept. of Neurology, Klinikum Ludwigshafen

Ludwigshafen, Germany

Outcomes

Primary Outcomes

Death

death of participating ALS patients independent of the cause of death

Time frame: an average of 3 years

Secondary Outcomes

Tracheostomy

tracheostomy in ALS patients following respiratory failure

Time frame: an average of 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.